Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Kern

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Developmental Cell|March 27, 2019
TAZ Forces Lateral InhibitionJoseph G Kern, Xaralabos Varelas
Protein & Cell|July 28, 2017
The emerging role and targetability of the TCA cycle in cancer metabolismNicole M Anderson, Patrick Mucka, Joseph G Kern, et al.
EMBO Reports|February 14, 2025
LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated nicheJoseph G Kern, Lina Kroehling, Anthony J Spinella, et al.
Frontiers in Genetics|March 7, 2019
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic FeaturesVinay K Kartha, Paola Sebastiani, Joseph G Kern, et al.
Cancers|July 30, 2020
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF SignalingAthanasios Pseftogas, Konstantinos Xanthopoulos, Theofilos Poutahidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2021
Aberrant epithelial polarity cues drive the development of precancerous airway lesionsAndrew Tilston-Lunel, Sarah Mazzilli, Nathan M Kingston, et al.
Nature Communications|November 28, 2022
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomasJoseph G Kern, Andrew M Tilston-Lunel, Anthony Federico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2017
Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanomaLauryn R Werner, Jasdeep S Kler, Monica M Gressett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Developmental Cell|March 27, 2019
TAZ Forces Lateral InhibitionJoseph G Kern, Xaralabos Varelas
Protein & Cell|July 28, 2017
The emerging role and targetability of the TCA cycle in cancer metabolismNicole M Anderson, Patrick Mucka, Joseph G Kern, et al.
EMBO Reports|February 14, 2025
LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated nicheJoseph G Kern, Lina Kroehling, Anthony J Spinella, et al.
Frontiers in Genetics|March 7, 2019
CaDrA: A Computational Framework for Performing Candidate Driver Analyses Using Genomic FeaturesVinay K Kartha, Paola Sebastiani, Joseph G Kern, et al.
Cancers|July 30, 2020
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF SignalingAthanasios Pseftogas, Konstantinos Xanthopoulos, Theofilos Poutahidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2021
Aberrant epithelial polarity cues drive the development of precancerous airway lesionsAndrew Tilston-Lunel, Sarah Mazzilli, Nathan M Kingston, et al.
Nature Communications|November 28, 2022
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomasJoseph G Kern, Andrew M Tilston-Lunel, Anthony Federico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2017
Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanomaLauryn R Werner, Jasdeep S Kler, Monica M Gressett, et al.
Pageof 1